SMO Clinplus Co

SMO Clinplus Co EBIT per Share

The EBIT per Share of SMO Clinplus Co (301257.SZ) as of Nov 4, 2026 is 1.69 CNY. In the previous year, EBIT per Share was 1.45 CNY — a change of 16.73% (higher).

EBIT per Share

1.69CNY

YoY

16.73%

Last updated:

EBIT per Share of SMO Clinplus Co is 2025 1.69 CNY. EBIT per Share of SMO Clinplus Co was 2024 1.45 CNY. It decreases by 16.73% higher compared to the previous year.

The SMO Clinplus Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
0.59 CNY
Jan 1, 2021
0.92 CNY
Jan 1, 2022
1.30 CNY
Jan 1, 2023
1.95 CNY
Jan 1, 2024
1.45 CNY
Jan 1, 2025
1.69 CNY
Jan 1, 2026 (e)
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
The SMO Clinplus Co EBIT per Share history
YEAREBIT per ShareYoY
est0.00CNY—
est0.00CNY-100.00%
1.69CNY+16.73%
1.45CNY-25.76%
1.95CNY+49.83%
1.30CNY+41.08%
0.92CNY+56.35%
0.59CNY-23.27%
0.77CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMO Clinplus Co Stock analysis

What does SMO Clinplus Co do? SMO ClinPlus Co., Ltd. generates revenue by offering site management organization (SMO) services for clinical research and development to pharmaceutical companies, medical device companies, and health-related product developers. The company provides comprehensive services including pre-preparation planning, site start-up, on-site execution, and full-process project management. Its primary clients are domestic and foreign pharmaceutical firms, medical device manufacturers, and health product R&D entities operating in both domestic and international markets. The firm's service model focuses on supporting clinical trials through end-to-end management, targeting companies engaged in drug development and medical device testing. By delivering tailored SMO solutions, SMO ClinPlus serves the needs of clients requiring efficient site management for their clinical research activities. The company's operations span across domestic and overseas markets, serving a broad range of healthcare industry participants. SMO Clinplus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMO Clinplus Co stock

EBIT per Share of SMO Clinplus Co is 1.69 CNY in 2025.

EBIT per Share of SMO Clinplus Co changed from 1.45 CNY to 1.69 CNY, representing a 16.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share SMO Clinplus Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SMO Clinplus Co

All Key Metrics — SMO Clinplus Co